XML 86 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Shareholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Schedule of Consolidated Balance Sheets [Abstract]  
Schedule of Consolidated Balance Sheets Consolidated Balance Sheets as of December 31, 2022
   Pre-share
consolidation		   Adjustments   Post-share
consolidation		 
(Deficit) Equity            
Number of ordinary shares – authorized   300,000,000    (292,500,000)   7,500,000 
Number of ordinary shares – issued and outstanding   64,770,529    (63,151,552)   1,618,977 
Par value  $0.003   $0.117   $0.12 
Schedule of Consolidated Statements of Profit or Loss Consolidated Statements of Profit or Loss for the year ended December 31, 2022
   Pre-share consolidation   Adjustments   Post-share consolidation 
Loss per share            
Basic and diluted loss for the year attributable to ordinary equity holders of the Company  $(0.37)  $(14.60)  $(14.97)
                
Weighted average number of shares used in computation:               
Basic and diluted   49,605,434    (48,365,582)   1,239,852 

 

Consolidated Statements of Profit or Loss for the year ended December 31, 2021
   Pre-share consolidation   Adjustments   Post-share consolidation 
Loss per share            
Basic and diluted loss for the year attributable to ordinary equity holders of the Company  $(0.31)  $(11.59)  $(11.90)
                
Weighted average number of shares used in computation:               
Basic and diluted   17,537,238    (17,076,519)   460,719